legaglycin

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namelegaglycin
Drug Alias Namehypoglycemic peptide (Huazhong Institute of Science and Technology)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionInsulin release stimulants
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesHuazhong University Of Science And Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHuazhong University Of Science And Technology
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A